BOOM-IBD2 Clinical Trial to Evaluate the Effectiveness of Sacral Neuromodulation for the Treatment of IBD.
Status: Recruiting
Location: See all (10) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The BOOM-IBD2 clinical trial is designed to evaluate the effectiveness of sacral neuromodulation for the treatment of IBD.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:
• Male or female
• 18 to 85 years of age
• Diagnosed with ulcerative colitis
• Ability and willingness to consent to participate by signing the informed consent form
• Ability to comply with the protocol and willingness to comply with all follow up requirements
Locations
United States
California
Center for Colorectal Innovation
RECRUITING
Los Angeles
Hoag Hospital
RECRUITING
Newport Beach
PAMF (Palo Alto Medical Foundation)
RECRUITING
Palo Alto
Kansas
Kansas Gastro
RECRUITING
Wichita
Missouri
Objective Health - St. Louis
RECRUITING
St Louis
North Carolina
UNC Chapel Hill
RECRUITING
Chapel Hill
Nevada
Las Vegas Medical Research LLC, DBA Vector Clinical Trials
RECRUITING
Las Vegas
New York
Columbia University Irving Medical Center/New York Presbyterian Hospital
RECRUITING
New York
Texas
Objective Health - Amarillo
RECRUITING
Amarillo
Objective Health - Central Texas
RECRUITING
Waco
Contact Information
Primary
Malea D'Amico
mdamico@boomerangmedical.com
844-423-9747
Backup
Colleen Holthe
colleen@boomerangmedical.com
844-423-9747
Time Frame
Start Date: 2025-01-31
Estimated Completion Date: 2026-10
Participants
Target number of participants: 137
Treatments
Experimental: Treatment Arm
Patients implanted with neuromodulation
Related Therapeutic Areas
Sponsors
Leads: Boomerang Medical